Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridinyl derivatives

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 856-864

  Inoue, Hiroyuki ^a   Castagnoli, Kay ^a   Van Der Schyf, Cornelis ^a   Mabic, Stephane ^a   Igarashi, Kazuo ^b   Castagnoli Jr , Neal ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CLORGYLINE; DIHYDROPYRIDINE DERIVATIVE; DRUG METABOLITE; SELEGILINE;

ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CATTLE; CONTROLLED STUDY; DRUG OXIDATION; DRUG RESEARCH; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; HUMAN TISSUE; LIVER MITOCHONDRION; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RABBIT; RAT; SPECIES DIFFERENCE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; CATTLE; CLORGYLINE; DOGS; HUMANS; MACACA FASCICULARIS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MITOCHONDRIA; MITOCHONDRIA, LIVER; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PAPIO; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SELEGILINE; SPECIES SPECIFICITY; SPECTROPHOTOMETRY;

EID: 0032696105     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bai H (1991) Synthetic and metabolic studies on 1-methyl-4-(1-methyl-2-pyrrolyl)-1,2,3,6-tetrahydropyridine, a neurotoxic analog of the parkinsonian inducing agent MPTP. Master's thesis, Virginia Polytechnic Institute and State University, Blacksburg, VA.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Castagnoli N Jr, Rimoldi JM, Bloomquist J and Castagnoli KP (1997) Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes. Chem Res Toxicol 10:924-940.
4. Chiba K, Peterson LA, Castagnoli KP, Trevor AJ and Castagnoli N Jr (1985) Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Drug Metab Dispos 13: 342-347.
5. Di Monte DA, Schipper HM, Hetts S and Langston JW (1995) Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures. Glia 15:203-206.
6. Flaherty P, Castagnoli K, Wang YX and Castagnoli N Jr (1996) Synthesis and selective monoamine oxidase B-inhibiting properties of 1-methyl-1,2,3,6-tetrahydropyrid-4-yl carbamate derivatives: Potential prodrugs of (R)- and (S)-nordeprenyl. J Med Chem 39:4756-4761.
7. Garrick NA and Murphy DL (1980) Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology 72:27-33.
8. Gómez N, Balsa D and Unzeta M (1988) A comparative study of some kinetic and molecular properties of microsomal and mitochondrial monoamine oxidase. Biochem Pharmacol 37:3407-3413.
9. Guengerich FP (1997) Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem-Biol Interact 106:161-182.
10. Hauptmann N, Grimsby J, Shih JC and Cadenas E (1996) The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch Biochem Biophys 335:295-304.
11. Holt A, Alton G, Scaman CH, Loppnow GR, Szpacenko A, Svendsen I and Palcic MM (1998) Identification of the quinone cofactor in mammalian semicarbazide-sensitive amine oxidase. Biochemistry 7:4946-4957.
12. Kalaria RN, Mitchell MJ and Harik SI (1988) Monoamine oxidases of the human brain and liver. Brain 111:1441-1451.
13. Kalgutkar A, Castagnoli K, Hall A and Castagnoli N Jr (1994) Novel 4-(aryloxy) tetrahydropyridine analogs of MPTP as monoamine oxidase A & B substrates. J Med Chem 37:944-949.
14. Kalgutkar AS and Castagnoli N Jr (1995) Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism. Med Res Rev 15:325-388.
15. Krueger MG, Mazouz F, Ramsay RR, Milcent R and Singer TP (1995) Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors. Biochem Biophys Res Commun 206:556-562.
16. Mabic S and Castagnoli N Jr (1998) Studies on the electron-impact-induced fragmentation of 1,4-disubstituted-1,2,3,6-tetrahydropyridines. J Mass Spect Soc Jpn 46:17-24.
17. 3H]harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat. J Neurochem 56:500-508.
18. Murphy DL, Redmond DE Jr, Garrick N and Baulu J (1979) Brain region differences and some characteristics of monoamine oxidase type A and B activities in the vervet monkey. Neurochem Res 4:53-62.
19. Nimkar SK, Anderson A, Rimoldi JM, Stanton M, Castagnoli KP, Mabic S, Wang Y-X and Castagnoli N Jr (1996) Synthesis and monoamine oxidase-B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives. Chem Res Toxicol 9:1013-1022.
20. O'Brien E, Dostert P and Tipton KF (1995) Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B. Biochem Pharmacol 50:317-324.
21. +, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J Med Chem 28:1432-1436.
22. Riachi NJ and Harik SI (1992) Monoamine oxidases of the brains and livers of macaque and cercopithecus monkeys. Exp Neurol 115:212-217.
23. Salach JI and Weyler W (1987) Preparation of the flavin-containing aromatic amine oxidases of human placenta and beef liver. Methods Enzymol 42:627-637.
24. 3H-Ro 19-6327 in vitro: Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J Neurosci 12:1977-1999.
25. Saura J, Nadal E, van den Berg B, Vila M, Bombi JA and Mahy N (1996) Localization of monoamine oxidases in human peripheral tissues. Life Sci 59:1341-1349.
26. Silverman RB (1995) Radical ideas about monoamine oxidase. Acc Chem Res 28: 335-342.
27. Singer TP and Ramsay RR (1991) The interaction of monoamine oxidases with tertiary amines. Biochem Soc Trans 19:211-215.
28. Strolin Benedetti M and Tipton KF (1998) Monoamine oxidases and related amine oxidases as phase I enzymes in the metabolism of xenobiotics. J Neural Transm Suppl 52:149-171.
29. Trendelenburg U, Cassis L, Grohmann M and Langeloh A (1987) The functional coupling of neuronal and extraneuronal transport with intracellular monoamine oxidase. J Neural Transm Suppl 23:91-101.
30. Trevor AJ, Singer TP, Ramsay RR and Castagnoli N Jr (1987) Processing of MPTP by monoamine oxidase: Implications for molecular toxicology. J Neural Transm Suppl 23:73-89.
31. Waldmeier PC (1987) Amine oxidases and their endogenous substrates. J Neural Transm Suppl 23:55-72.
32. Willoughby J, Glover V, Sandier M, Albanese A, Jenner P and Marsden CD (1988) Monoamine oxidase activity and distribution in marmoset brain: Implications for MPTP toxicity. Neurosci Lett 90:100-106.
33. Wouters J (1998) Structural aspects of monoamine oxidase and its reversible inhibition. Curr Med Chem 5:137-162.
34. Youngster SK, Sonsalla PK and Heikkila RE (1987) Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 48:929-934.
35. Yu J and Castagnoli N Jr (1999) Synthesis and MAO-B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines. Bioorg Med Chem 6:1-9.
36. Yu PH, Davis BA and Boulton AA (1992) Neuronal and astroglial monoamine oxidase: Pharmacological implications of specific MAO-B inhibitors. Prog Brain Res 94:309-315.